Pliant Therapeutics (PLRX) Operating Leases (2021 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Operating Leases of $28.8 million for Q1 2026, down 3.7% year-over-year from $29.9 million in Q1 2025, and up 4.07% quarter-over-quarter from $27.7 million in Q4 2025.
Pliant Therapeutics (PLRX) Operating Leases (2021 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Operating Leases for 6 consecutive years, with $28.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 3.7% year-over-year to $28.8 million; the TTM figure through Mar 2026 stood at $28.8 million (down 3.7% YoY), while the FY2025 annual figure was $27.7 million, down 6.05% from the prior year.
- Operating Leases climbed to $28.8 million in Q1 2026 per PLRX's latest filing, from $27.7 million in the prior quarter.
- Across five years, Operating Leases topped out at $30.0 million in Q2 2025 and bottomed at $2.3 million in Q2 2023.
- Historically, Operating Leases has averaged $17.4 million across 5 years, with a median of $23.7 million in 2024.
- Annual changes were most pronounced in 2023 — Operating Leases tumbled 64.06% — and 2024, when it soared 731.58%.
- Pliant Therapeutics' Operating Leases stood at $3.4 million in 2022, then slumped by 32.4% to $2.3 million in 2023, then soared by 1170.02% to $29.4 million in 2024, then dropped by 6.05% to $27.7 million in 2025, then climbed by 4.07% to $28.8 million in 2026.
- Business Quant data shows PLRX's Operating Leases at $28.8 million in Q1 2026, $27.7 million in Q4 2025, and $29.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Pliant Therapeutics | 71.52 Mn | 71.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.74 Mn |
| Mar 31, 2026 | 28.78 Mn |
| Dec 31, 2025 | 27.66 Mn |
| Sep 30, 2025 | 29.42 Mn |
| Jun 30, 2025 | 30.02 Mn |
| Mar 31, 2025 | 29.89 Mn |
| Dec 31, 2024 | 29.44 Mn |
| Sep 30, 2024 | 29.75 Mn |
| Jun 30, 2024 | 6.10 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Jun 30, 2023 | 2.32 Mn |
| Mar 31, 2023 | 2.85 Mn |
| Dec 31, 2022 | 3.43 Mn |
| Sep 30, 2022 | 4.13 Mn |
| Jun 30, 2022 | 6.45 Mn |
| Mar 31, 2022 | 6.92 Mn |
| Dec 31, 2021 | 5.33 Mn |